Alpha-Synuclein Antibodies (7A11)

Treatment of CNS Disorders Associated with Mutations in Genes Encoding Lysosomal Enzymes

METHOD FOR IDENTIFYING PARKINSON DISEASE DEMENTIA FROM PARKINSON DISEASE

Antibodies for the treatment of synucleinopathy

Antibodies for the treatment of synucleinopathy

Methods for Inhibiting the Development of Huntington's Disease

Compositions and methods for detecting proteinopathies

ANTIBODIES AGAINST MAMMAL SECRETED KLOTHO PROTEIN

LABEL-FREE SINGLE AND MULTI-PHOTON FLUORESCENCE SPECTROSCOPY TO DETECT BRAIN DISORDERS AND DISEASE: ALZHEIMER, PARKINSON AND AUTISM FROM BRAIN TISSUE, CELLS, SPINAL FLUID AND BODY FLUIDS

Erythrocyte-derived extracellular vesicles as a biomarker for clinically assessing Parkinson's disease

BIOMARKER FOR PARKINSON'S DISEASE AND USE THEREOF

Monitoring control channel with different encoding schemes

Systems and methods for screening a sample based on multiple reaction monitoring mass spectrometry

Method of treating neurological conditions with oleandrin

CHEMICAL MODEL OF A NEURODEGENERATIVE DISEASE, METHOD FOR PREPARATION AND USES OF SAME

Glucagon/GLP-1 receptor co-agonists

A PARKINSON'S DISEASE DIAGNOSTIC BIOMARKER PANEL

ANTI-ALPHA-SYNUCLEIN ANTIBODIES AND METHODS OF USE

Detection of aggregated proteins associated with neurodegenerative disease using a photooxidation-induced amplification immunoassay

Compounds for use as imaging agents

YEAST SCREENS FOR TREATMENT OF HUMAN DISEASE

Substances and methods for the use in prevention and/or treatment in Huntington's disease

Biomarkers for risk assessment, diagnosis and target microbiome and intestinal homeostasis for prevention and treatment of amyotrophic lateral sclerosis

Biomarkers of congnitive dysfunction

Sprr1A as a genetic target for treating neurodegenerative diseases

METHOD FOR DETECTING AGGREGATE FORM OF AGGREGATE-FORMING POLYPEPTIDE

AMYOTROPHIC LATERAL SCLEROSIS (ALS) BIOMARKERS AND USES THEREOF

Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s)

Anti-alpha synuclein binding molecules

Hydroxycholesterol immunoassay

Antibodies to Alpha Synuclein

Therapeutic and Diagnostic Method for Ataxia-Telangiectasia

Method for diagnostics, treatment and prevention of Parkinson's disease

USE OF LEUKOCYTES AND NOVEL BIOMARKERS IN THE DIAGNOSIS, CONFIRMATION, AND TREATMENT OF A NEUROLOGICAL DISORDER

Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder

Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder

NEURAL SPECIFIC S100-BETA FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION

Human derived anti-Huntingtin (HTT) antibodies and uses thereof

Method for detecting GABAA receptor autoantibodies

Methods of identifying and monitoring mitochondrial dysfunction using monocyte screening

Substances and methods for the use in prevention and/or treatment in Huntington's disease

Pharmaceutical composition for preventing or treating neurodegenerative diseases

Diagnostic methods for neural disorders

ANTIBODIES TO DISULFATED HEPARIN DISACCHARIDE IN THE DIAGNOSIS OF NEUROPATHY

METHODS AND COMPOSITIONS FOR TREATMENT OF MACROPHAGE-RELATED DISORDERS

METHOD FOR ENRICHING CNS-DERIVED EXOSOMES

Immobilized protein system for rapid and enhanced multiplexed diagnostics

Label-Free Single and Multi-Photon Fluorescence Spectroscopy to Detect Brain Disorders and Diseases: Alzheimer, Parkinson, and Autism From Brain Tissue, Cells, Spinal Fluid, and Body Fluids

Systems, apparatus, and methods for analyzing and predicting cellular pathways

Traumatic Brain Injury and Neurodegenerative Biomarkers, Methods, and Systems

Device for detecting misfolded proteins and methods of use thereof

Agents, uses and methods for the treatment of synucleinopathy

Biomarker for parkinson's disease and use thereof

Attenuated total reflectance-based biosensor for conformation and secondary structure analysis

Methods of using an activator of cereblon for neural cell expansion and the treatment of central nervous system disorders

In Vitro Method of Diagnosing Parkinson's Disease

CELLULAR RESPONSE ASSAY FOR BIOFLUID BIOMARKER DISCOVERY AND DETECTION

SOLUBLE HIGH MOLECULAR WEIGHT (HMW) TAU SPECIES AND APPLICATIONS THEREOF

Methods for Diagnosing Onset and Monitoring Progression of Huntington's Disease

METHOD OF DISTINGUISHING BETWEEN DIFFERENT NEURODEGENERATIVE DISEASES

Compositions for diagnosing episodic movement disorders and related conditions

Predicting therapeutic response in Parkinson's disease

Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder

Methods for the diagnosis and treatment of neurological and neurodegenerative diseases, disorders and associated processes

ASSAY TO DETERMINE LRRK2 ACTIVITY IN PARKINSON'S DISEASE

Method for isolating apoptotic bodies

DYES FOR ANALYSIS OF PROTEIN AGGREGATION

Monitoring immunotherapy of Lewy body disease from constipation symptoms

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

CHIMERIC PROTEIN IN THE TREATMENT OF AMYLOIDOSIS

Method for preparation of induced dopaminergic progenitors using direct reprogramming

Methods for treating spinocerebellar ataxia type I using RPA1

Method of Identifying Biomarkers of Neurological Diseases and Diagnosis of Neurological Diseases

Method of treating neurological conditions with oleandrin

Early stage Parkinson's disease diagnostic kits and methods

METHOD OF SCREENING FOR COMPOUNDS USEFUL IN THE TREATMENT OF HUNTINGTON DISEASE

Therapeutic and Diagnostic Method for Ataxia-Telangiectasia

Diagnostic and monitoring system for Huntington's disease

KINETICS BIOMARKERS FOR NEURODEGENERATION

Blood-based screen for detecting neurological diseases in primary care settings

Ameliorating nervous systems disorders

Anti-α-synuclein antibodies and methods of use

Methods for diagnosis and treatment of amyotrophic lateral sclerosis based on an increased level of interaction between TDP-43 polypeptide and NF-KB P65 polypeptide

Detection of misfolded alpha synuclein protein

FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving Tau dysfunction

Modulators of alpha-synuclein toxicity

Compositions and methods for assessing neuromuscular function

Use and treatment of di-amino acid repeat-containing proteins associated with ALS

Compositions and methods for predicting age of onset of a lysosomal storage disease or a disease associated with a lysosomal defect

ASSAY METHOD

Assay to determine LRRK2 activity in parkinson's disease

Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications

Glucagon/GLP-1 receptor co-agonists

Chemical model of a neurodegenerative disease, method for preparation and uses of same

Method for diagnosing neurodegenerative diseases

Antibodies that bind amyloid oligomers

Method for detection of aggregates in biological samples

Method for the determination of conformation and conformational changes of proteins and of derivatives thereof

Diagnostic method based on large scale identification of post-translational modification of proteins

Synthetic analogues of neural regeneration peptides

Lrp4/corin dopamine-producing neuron precursor cell marker

Method for detecting neurological disease accompanied by inflammation and/or demyelination

Methods for identifying candidates for the treatment of neurodegenerative diseases

Immunoassay of S-adenosylmethionine in personalized medicine and health or cancer evaluation

CD44 splice variants in neurodegenerative diseases

Novel Gene Targets Associated with Amyotrophic Lateral Sclerosis and Methods of Use Thereof

Method for diagnosing a neurodegenerative disease

DETECTION OF NEUROLOGICAL DISEASES VIA MEASUREMENT OF NEUROMELANIN IN RECIRCULATING PHAGOCYTES

HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES

COVALENTLY BOUND METABOLITES AS BIOMARKERS

Immortalized mesenchymal stromal cell from adipose tissue

Method for treating muscle wasting syndrome using antagonist antibodies against GDF-8

NEURAL SPECIFIC S100B FOR BIOMARKER ASSAYS AND DEVICES FOR DETECTION OF A NEUROLOGICAL CONDITION

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other α-synucleinopathies

Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes

Biomarkers and diagnostic methods for Alzheimer's disease and other neurodegenerative disorders

Parkinson's Disease Biomarker

NEUREGULIN ISOFORMS, NEUREGULIN POLYPEPTIDES AND USES THEREOF

METHOD FOR IDENTIFYING DISEASE ASSOCIATED WITH ABUNDANCE OF TDP-43 IN CELL

STANDARD FOR QUANTIFYING PATHOGENIC AGGREGATES FROM PROTEINS PRODUCED NATURALLY IN THE BODY

COMPOSITIONS AND METHODS FOR HIGH-THROUGHPUT SCREENING IN SKIN FIBROBLASTS WITH AN ALPHA-SYNUCLEIN TRIPLICATION

Method for the assay of synucleins

Method for diagnosing or prediagnosing a beta-amyloidopathy or an alpha-synucleopathy

METHODS OF DIAGNOSING TAU-ASSOCIATED NEURODEGENERATIVE DISEASES

Conformational-switching fluorescent protein probe for detection of alpha synuclein oligomers

Transcriptional repression leading to parkinson's disease

Two-photon absorbing compound with methods of synthesis and use

Anti-α synuclein binding molecules

Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease

Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies

Therapeutic approach for polyglutamine degeneration

METHODS OF DIAGNOSING AND TREATING AMYOTROPHIC LATERAL SCLEROSIS

Method for diagnosing and treating Parkinson's disease via measurment of effector memory t-cells

Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities

Methods for inhibiting the development of Huntington's disease

Biomarkers for prediction, diagnosis, and monitoring of Alzheimer's disease

Biomarkers for prediction, diagnosis, and monitoring of parkinson's disease

Yeast screens for treatment of human disease

Methods for analyzing blood to detect diseases associated with abnormal protein aggregation

Methods and compositions for the treatment of huntington's disease

3,7-diamino-10H-phenothiazine salts and their use

Glucagon/GLP-1 receptor co-agonists

FKBP52-Tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction

Methods for detecting a genetic variation in subjects with parkinsonism

Therapeutic and diagnostic method for ataxia-telangiectasia

Assay to determine LRRK2 activity in parkinson's disease

Therapeutic applications targeting SARM1

Ice-cleaved alpha-synuclein as a biomarker

Protofibril-binding antibodies and their use in thereapeutic and diagnostic methods for parkinson's disease, dementia with lewy bodies and other alpha-synucleinopathies

Methods for diagnosing episodic movement disorders and related conditions

Development and screening of contrast agents for in vivo imaging of Parkinson's disease

Phosphodiesterase activity and regulation of phosphodiesterase 1B-mediated signaling in brain

Synthetic analogues of neural regeneration peptides

Ameliorating nervous systems disorders

Method for diagnosing and monitoring schizophrenia and tauopathies

BIOMARKERS FOR SANFILIPPO SYNDROME AND USES THEREOF

Humanized antibodies that recognize alpha-synuclein

Treating neurological disorders

Antibodies to alpha synuclein

METHOD OF DIAGNOSING TRICHOTILLOMANIA AND SIMILAR DISORDERS IN HUMANS AND RODENTS

METHODS OF USING HUMAN PROTEIN KINASE C DELTA VIII AS A BIOMARKER

Gene targets associated with amyotrophic lateral sclerosis and methods of use thereof

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

Compositions and methods for modulating dopamine neurotransmission

Method of Detecting and Profiling Progression of the Risk of Neurodegenerative Diseases

YEAST SCREENS FOR TREATMENT OF HUMAN DISEASE

Glucagon/GLP-1 receptor co-agonists

Glucagon/GLP-1 receptor co-agonists

Therapeutic Applications Targeting SARM1

Protofibril-binding antibodies and their use in therapeutic and diagnostic methods for Parkinson's disease, dementia with lewy bodies and other α-synucleinopathies

FKBP52-tau interaction as a novel therapeutical target for treating the neurological disorders involving tau dysfunction

SPECIFIC SALIVARY BIOMARKERS FOR RISK DETECTION, EARLY DIAGNOSIS, PROGNOSIS AND MONITORING OF ALZHEIMER'S AND PARKINSON'S DISEASES

Neuroprotective ganglioside compositions for use in treating huntington's disease

COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF MITOCHONDRIAL DISEASES

NEUROTROPHINS AND USES THEREOF

CELLULAR RESPONSE ASSAY FOR BIOFLUID BIOMARKER DISCOVERY AND DETECTION

FIBROSIS INHIBITOR

BIOMARKER FOR NEURODEGENERATION IN NEUROLOGICAL DISEASE

METHODS OF DIAGNOSING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

DIAGNOSTIC AGENT FOR PARKINSON'S DISEASE

Antibodies to disulfated heparin disaccharide in the diagnosis of neuropathy

TREATING NEUROLOGICAL DISORDERS

Specific marker Lmx1a on dopaminergic neurons

OXIDATIVE STRESS MEASUREMENT DEVICE AND RELATED METHODS

Compositions and Methods for Modulating PGC-1Alpha to Treat Neurological Diseases and Disorders

MEANS AND METHODS FOR COUNTERACTING POLYQ EXPANSION DISORDERS

COMPOSITIONS AND MODULATION OF MYOCYTE ENHANCER FACTOR 2 (MEF2)

Antibodies that bind amyloid oligomers

Transcriptional repression leading to Parkinson's disease

Hydroxycholesterol immunoassay

DIAGNOSIS OF NEUROPSYCHIATRIC AND BEHAVIOURAL DISORDERS

PARKIN SUBSTRATE AND ASSAY

MITOCHONDRIAL INHIBITORS AND USES THEREOF

p16 MEDIATED REGULATION OF NMDA RECEPTORS

IRAK KINASE FAMILY AS NOVEL TARGET AND BIOMARKER FOR ALZHEIMER

Polynucleotides encoding antagonist antibodies against GDF-8

METHOD FOR THE PREVENTION AND TREATMENT OF ESSENTIAL TREMOR BY REGULATING alpha1G T-TYPE CALCIUM CHANNEL OR BY T-TYPE CALCIUM CHANNEL BLOCKERS

ANIMAL MODEL FOR PARKINSON'S DISEASE

Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions

Method for treating muscular dystrophy using antagonist antibodies against GDF-8

Compositions and methods for treatment of neurodegenerative diseases

COMPOSITION FOR DIAGNOSING PARKINSON'S DISEASE CONTAINING ADIPOSE TISSUE-DERIVED MESENCHYMAL STROMAL CELL

Yeast Screens for Treatment of Human Disease

Human anti-alpha-synuclein antibodies

Methods for identifying modulators of LRRK2

Yeast-based methods of identifying nucleic acids and compounds for treating neurodegenerative diseases

Methods and compositions for the treatment of Huntington'S disease

SCREENING METHOD FOR POLYMORPHIC MARKERS IN HTRA1 GENE IN NEURODEGENERATIVE DISORDERS

ALPHA-SYNUCLEIN KINASE

MONOCLONAL ANTIBODIES SPECIFIC FOR PATHOLOGICAL AMYLOID AGGREGATES COMMON TO AMYLOIDS FORMED FROM PROTEINS OF DIFFERING SEQUENCE

MARKER SEQUENCE FOR NEURODEGENERATIVE DISEASES AND THE USE THEREOF

Use of 14-3-3-Proteins in Treatment and Prevention of Neurodegeneration

CD44 splice variants in neurodegenerative diseases

Method of treating neurological conditions with cardiac glycoside

Ameliorating Nervous Systems Disorders

METHODS AND KITS FOR DIAGNOSING NEURODEGENERATIVE DISEASE

Model Systems and Materials for the Study and Treatment of Neurodegenerative Diseases

MODULATION OF NEURODEGENERATIVE DISEASE BY MODULATING XBP-1 ACTIVITY

BIOASSAY FOR POLYQ PROTEIN

Dyes and compositions, and processes for using same in analysis of protein aggregation and other applications

3,7-diamino-10H-phenothiazine salts and their use

TARGET SEQUENCES AND METHODS TO IDENTIFY THE SAME, USEFUL IN TREATMENT OF NEURODEGENERATIVE DISEASES

Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes

Biomarkers for amyotrophic lateral sclerosis

Synthetic analogues of neural regeneration peptides

Compositions and methods for modulating dopamine neurotransmission

MOLECULAR TARGETS AND COMPOUNDS, AND METHODS TO IDENTIFY THE SAME, USEFUL IN THE TREATMENT OF NEURODEGENERATIVE DISEASES

Methods for inhibiting the development of huntington's disease

COMPOSITIONS AND METHODS OF TREATMENT USING MODULATORS OF MOTONEURON DISEASES

MAO-B ELEVATION AS AN EARLY PARKINSON'S DISEASE BIOMARKER

Method for detecting disease markers

Therapy for hyperexcitability disorders

Identification of small molecules recognized by antibodies in subjects with neurodegenerative diseases

NEUROPROTECTION AND PREVENTION OF DOPAMINERGIC CELL DEATH BY TARGETING NUR77 TRANSLOCATION

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Compounds for the Modulation of Huntingtin Aggregation, Methods and Means for Identifying Such Compounds

COMPOSITIONS AND METHODS FOR MODULATING TLR14 ACTIVITY

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

CYCLOPHILIN D-AMYLOID BETA INTERACTION POTENTIATES MITOCHONDRIAL DYSFUNCTION IN A TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood GLP-1 level

Methods for identifying GLP-1 secretagogues

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

METHODS OF IDENTIFYING HISTONE DEACETYLASE INHIBITORS USEFUL FOR NEUROLOGICAL DISORDERS

Diagnostic agent

Methods of Identifying Improved NMDA Receptor Antagonists

Methods for treating cone dystrophy with neuronal viability factor, RDCVF2

MEASUREMENT OF NEURAL ACTIVITY

Methods for diagnosing episodic movement disorders and related conditions

METHODS FOR TESTING FOR AND INHIBITING THE DEVELOPMENT OF HUNTINGTON'S DISEASE

DIAGNOSTIC TEST FOR PARKINSON'S DISEASE

DIAGNOSTIC METHOD

FIBROSIS INHIBITOR

Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress

Compositions and Methods for Detecting and Quantifying Toxic Substances in Disease States

p16 MEDIATED REGULATION OF NMDA RECEPTORS

DIAGNOSTIC METHOD BASED ON LARGE SCALE IDENTIFICATION OF POST-TRANSLATIONAL MODIFICATION OF PROTEINS

REDUCING POLYGLUTAMINE-BASED AGGREGATION

COMBINATION THERAPY FOR THE TREATMENT OF DIABETES AND CONDITIONS RELATED THERETO AND FOR THE TREATMENT OF CONDITIONS AMELIORATED BY INCREASING A BLOOD GLP-1 LEVEL

CELLS EXPRESSING ALPHA-SYNUCLEIN AND USES THEREFOR

Detection and/or Characterisation of Oligomers

PROTECTIVE EFFECTS OF INHIBITING THE INTERACTION OF CALMODULIN AND MUTANT HUNTINGTIN PROTEIN

Methods of identifying LRRK2 inhibitors

Method for detecting aggregate-forming circulating protein forms using an agent for aggregating said forms and an agent for capturing formed aggregates

Development of sensitive FRET sensors and methods of using the same

Diazoxide for the treatment of Friedreich's ataxia

Use of Androgens for the Treatment of Parkinson's Disease

ASSAY FOR PARKINSON'S DISEASE THERAPEUTICS AND ENZYMATICALLY ACTIVE PARKIN PREPARATIONS USEFUL THEREIN

METHODS FOR THE DIAGNOSIS OF PROLIFERATIVE AND/OR CONFORMATIONAL DISEASES

Modulators of alpha-synuclein toxicity

Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders

Method of making a molded food item from individual food pieces

Parkinson's Disease-Related Gene GRK5 and Uses Thereof

Method and device for producing shaped meat portions from whole natural meat pieces

IDENTIFICATION AND USE OF GPRC VARIANTS IN THE TREATMENT AND DIAGNOSIS OF PARKINSON'S DISEASE

METHOD FOR IDENTIFYING CRMP MODULATORS

METHODS AND MATERIALS RELATING TO ENHANCED PRODUCTION OF DOPAMINE NEURONS

Methods for the identification of LRRK2 interacting molecules

ESSENTIAL TREMOR DIAGNOSTIC AND TREATMENT

Inhibitors of protein aggregation

AGENTS FOR SUPPRESSING NEURAL FIBROTIC DEGENERATION

14-3-3 proteins for diagnosis of Parkinson's disease

CONFORMATIONAL ISOMERS OF ALPHA-SYNUCLEIN, ANTIBODIES THERETO AND METHODS OF THEIR MANUFACTURE AND USE

Compositions and methods for detecting compounds to treat a neurological disorder

Methods for identifying substances for the treatment of Alzheimer's disease

METHOD FOR THE PREVENTION AND TREATMENT OF ESSENTIAL TREMOR BY REGULATING ALPHA1G T-TYPE CALCIUM CHANNEL OR BY T-TYPE CALCIUM CHANNEL BLOCKERS

Biomarkers for neurodegenerative disorders

TREATING NEUROLOGICAL DISORDERS

ALLELE-SPECIFIC SILENCING OF DISEASE GENES

Assay method for identifying drug candidate

METHODS FOR PROMOTING DOPAMINERGIC NEURONAL DEVELOPMENT BY USING NG4A-SUBFAMILY AND WNT-LIGANDS

Antibodies and their use in the treatment, prevention and diagnosis of a disease associated with SOD1 abnormalities

Apolipoprotein E3 protein as a biomarker of Parkinson's disease

Peripherin and Neurofilament Light Protein Splice Variants in Amyotrophic Lateral Sclerosis (ALS)

Truncated Fragments of Alpha-Synuclein in Lewy Body Disease

Use of Sumoylation Inhibitors for the Treatment of Neurodegenerative Disease

Parkin substrate and assay